{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:49:55Z","timestamp":1697064595840},"reference-count":65,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,12,17]],"date-time":"2006-12-17T00:00:00Z","timestamp":1166313600000},"content-version":"vor","delay-in-days":3303,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT: <\/jats:bold> The role of primary genetic factors in the etiology of cancer has become of intense interest to the research and clinical community. This interest has been heightened by recent discoveries that germ\u2010line mutations such as BRCA1 and BRCA2 in hereditary breast cancer are responsible for an increasing percentage of common solid tumors. A potpourri of proto\u2010oncogenes and tumor\u2010suppressor genes has been identified in hereditary as well as certain common sporadic and rare cancer types, and new cancer genes will likely be discovered every month to account for the 5 to 10% of the cases of cancer that can be attributed to primary genetic factors.<\/jats:p><jats:p>Molecular mechanisms in the pathogenesis of hereditary cancer can result in more\u2010targeted cancer\u2010control measures. At least four mutator genes (MHS2, MLH1, PMS1 and PMS2) appear to account for 70\u201380% of hereditary nonpolypoid colorectal cancer (HNPCC). When one of these germ\u2010line mutations is present in an HNPCC family, the physician is then able to determine the patient's lifetime cancer destiny with an accuracy of about 90% (limited only by the penetrance of the gene). This will enable highly targeted surveillance to be initiated early, such as colonoscopy beginning at ages 20 to 25 or prophylactic subtotal colectomy. Also, in multiple endocrine neoplasia syndromes (MEN 2A and 2B), the identification of the culprit RET proto\u2010oncogene now enables a secure diagnosis and permits testing of children who might benefit from prophylactic total thyroidectomy.<\/jats:p><jats:p>Central to translation of these momentous molecular genetic discoveries into patient care is the necessity of determining who requires DNA testing. The cancer family history is the linchpin in making this decision.<\/jats:p>","DOI":"10.1111\/j.1749-6632.1997.tb48588.x","type":"journal-article","created":{"date-parts":[[2006,12,18]],"date-time":"2006-12-18T07:00:39Z","timestamp":1166425239000},"page":"1-28","source":"Crossref","is-referenced-by-count":16,"title":["Cancer Genetics in the New Era of Molecular Biology"],"prefix":"10.1111","volume":"833","author":[{"given":"HENRY T.","family":"LYNCH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAMON M.","family":"FUSARO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANE F.","family":"LYNCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,17]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.242.12.1268"},{"key":"e_1_2_14_3_2","first-page":"145","article-title":"Cancer and the family history trail","volume":"91","author":"Lynch H. T.","year":"1991","journal-title":"N.Y. State J. Med"},{"key":"e_1_2_14_4_2","first-page":"150","article-title":"The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer","volume":"91","author":"David K. L.","year":"1991","journal-title":"N.Y. State J. Med"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1913.00070050063006"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608876"},{"key":"e_1_2_14_8_2","first-page":"5302","article-title":"Colorectal cancer, pathology, survival, in HNPCC","volume":"16","author":"Lynch H. T.","year":"1997","journal-title":"Proceedings of ASCO"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81333-1"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899509002581"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02048279"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8612988"},{"key":"e_1_2_14_13_2","first-page":"1","article-title":"Muir\u2010Torre Syndrome: Heterogeneity, natural history, diagnosis, and management","volume":"10","author":"Lynch H. T.","year":"1993","journal-title":"Problems in General Surgery"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050298"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.46.1.5"},{"key":"e_1_2_14_16_2","volume-title":"Trait\u00e9 des tumeurs","author":"Broca P. P.","year":"1866"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1972.03210130023005"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2270482"},{"key":"e_1_2_14_19_2","first-page":"82","article-title":"Familial breast\u2010ovarian cancer locus on chromosome 17q12\u2010q23","volume":"388","author":"Narod S. A.","year":"1991","journal-title":"Lancet"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8091231"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/378789a0"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91578-4"},{"key":"e_1_2_14_24_2","first-page":"42","article-title":"A High Incidence of BRCA1 Mutations in 20 Breast\u2010Ovarian Cancer Families","volume":"58","author":"Serova O.","year":"1996","journal-title":"Am. J. Hum. Genet"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520310033026"},{"key":"e_1_2_14_26_2","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1 mutation carriers","volume":"56","author":"Easton D. F.","year":"1995","journal-title":"Am. J. Hum. Genet"},{"key":"e_1_2_14_27_2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotypephenotype correlation","volume":"11","author":"Gayther S. A.","year":"1995","journal-title":"Nature Genetics"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02586560"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(81)90063-3"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820715)50:2<360::AID-CNCR2820500233>3.0.CO;2-4"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611073351901"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800811038"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90253-B"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2134734"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000134370"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300903"},{"key":"e_1_2_14_39_2","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"Riccardi V. M.","year":"1992"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0596-114"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90885-G"},{"key":"e_1_2_14_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1988.tb02093.x"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.31.6.458"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199401000-00011"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1996.tb00435.x"},{"key":"e_1_2_14_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792600"},{"key":"e_1_2_14_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(96)00328-7"},{"key":"e_1_2_14_48_2","first-page":"17","article-title":"Heredity and malignant melanoma: Implications for early cancer detection","volume":"99","author":"Lynch H. T.","year":"1968","journal-title":"Can. Med. Assoc. J"},{"key":"e_1_2_14_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92822-7"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.15.5.352"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.20.1489"},{"key":"e_1_2_14_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-114"},{"key":"e_1_2_14_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/375506a0"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331504"},{"key":"e_1_2_14_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.203"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1981.225"},{"key":"e_1_2_14_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.209"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331505"},{"key":"e_1_2_14_59_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540190047028"},{"key":"e_1_2_14_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.20.1442"},{"key":"e_1_2_14_61_2","first-page":"4891","article-title":"Adenovirus\u2010based transfer of wild\u2010type p53 gene increases ovarian tumor radiosensitivity","volume":"56","author":"Gallardo D.","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_14_62_2","first-page":"4881","article-title":"The role of DNA mismatch repair in platinum drug resistance","volume":"56","author":"Fink D.","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_14_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.15.1114"},{"key":"e_1_2_14_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049703"},{"key":"e_1_2_14_65_2","volume-title":"Genetics and Breast Cancer","author":"Lynch H. T.","year":"1981"},{"key":"e_1_2_14_66_2","first-page":"107","article-title":"Hereditary ovarian cancer: Natural history, surveillance, management, and genetic counseling","volume":"2","author":"Lynch H. T.","year":"1994","journal-title":"Hem.-Onc. Ann"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.1997.tb48588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.1997.tb48588.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T04:22:52Z","timestamp":1695615772000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1997.tb48588.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1111\/j.1749-6632.1997.tb48588.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.1997.tb48588.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}